( MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Teladoc Health Inc. (“Teladoc” or the“Company”) (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at .
.. or 646-581-9980, (or 888.
4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
The class action concerns whether Teladoc and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. You have until July 16, 2024 , to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired Teladoc securities during the Class Period. A copy of the Complaint can be obtained a t .
[Click here for information about joining the class action] On February 20, 2024, Teladoc filed its annual report for 2023 with the U.S. Securities and Exchange Commission and held an earnings call to discuss the Company's results.
Among other items, Teladoc's annual report disclosed substantially higher advertising costs, reporting advertising and marketing spend of approximately $668.854 million, compared to $623.536 million in 2022.
Teladoc attributed the increase to“higher digital and media advertising costs related to BetterHelp”, the Company's online mental health counseling platform and its largest divisi.
